AngioDynamics, Inc. (ANGO)
11.04
-0.32
(-2.82%)
USD |
NASDAQ |
Mar 03, 16:00
11.04
0.00 (0.00%)
After-Hours: 20:00
AngioDynamics Research and Development Expense (Annual) : 26.22M for May 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Boston Scientific Corp. | 2.052B |
| Intuitive Surgical, Inc. | 1.312B |
| Masimo Corp. | 126.40M |
| Abbott Laboratories | 2.889B |
| Plus Therapeutics, Inc. | 10.58M |